8-K
Current Report
KYNTRA BIO, INC. Filed Acc 0000950170-23-033458
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading fgen-20230714.htm…